SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 56.11 |
| Enterprise Value ($M) | -24.43 |
| Book Value ($M) | 174.96 |
| Book Value / Share | 4.12 |
| Price / Book | 0.32 |
| NCAV ($M) | 168.97 |
| NCAV / Share | 3.97 |
| Price / NCAV | 0.33 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.47 |
| Return on Assets (ROA) | -0.33 |
| Return on Equity (ROE) | -0.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.45 |
| Current Ratio | 6.45 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 200.40 |
| Assets | 206.39 |
| Liabilities | 31.43 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | ARK Investment Management LLC | |||
| 13D/A | MPM BioVentures 2014, L.P. | |||
| 13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
| 13G/A | Redmile Group, LLC | 4.60 | -9.60 | |
| 13G/A | Blue Owl Capital Holdings LP | 7.93 | 8.01 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 35,787 | 134,492 | 26.61 | |
| 50,740 | 81,736 | 62.08 | |
| 32,724 | 123,989 | 26.39 | |
| 67,997 | 274,687 | 24.75 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RLYB – Rallybio Corporation | ROIV – Roivant Sciences Ltd. |
| RPRX – Royalty Pharma plc | RVMD – Revolution Medicines, Inc. |
| RXRX – Recursion Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io